Himont Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Pakistan pharmaceutical and herbal healthcare company with prescription, herbal, dermatology and consumer-health product lines.
Himont Pharmaceuticals products in Pakistan
Himont Pharmaceuticals (Pvt.) Ltd has 70 medicine presentations registered in Pakistan under 33 brands, covering 30 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Hematology & thrombosis. Its brands with the most registered strengths and packs are Clotles SS (Enoxaparin), Novosef (Ceftriaxone), Himet (Metformin) and Akafin (Ibuprofen). 70 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Private pharmaceutical manufacturer
- Website
- himont.com ↗
- Phone
- 042-35813828
- sales@himont.com
- Corporate source details checked
- 15 Oct 2026
- Corporate profile completeness
- 75%
Company location
No exact premises location is published without a defensible source.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Himont Pharmaceuticals (Pvt.) Ltd. is priced against the market
64 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Akafin | Ibuprofen | 200 mg | Tablet | 500's | 015854 | PKR 1,077.79 | PKR 2.16/tablet | 🔒 Pharma Pro |
| Akafin | Ibuprofen | 400 mg | Tablet | 250's | 015855 | PKR 903.63 | PKR 3.61/tablet | 🔒 Pharma Pro |
| Akafin | Ibuprofen | 100 mg/5 mL | Suspension | 90ml | 015857 | PKR 79.14 | PKR 0.88/mL | 🔒 Pharma Pro |
| Atrocard | Atorvastatin | 10 mg | Tablet | 10's | 031844 | PKR 447.51 | PKR 44.75/tablet | 🔒 Pharma Pro |
| Atrocard | Atorvastatin | 20 mg | Tablet | 10's | 031845 | PKR 764.36 | PKR 76.44/tablet | 🔒 Pharma Pro |
| Atrocard | Atorvastatin | 40 mg | Tablet | 10's | 031846 | PKR 1,042.30 | PKR 104.23/tablet | 🔒 Pharma Pro |
| Azomont | Azithromycin | 250 mg | Capsule | 1x6's | 027280 | PKR 341.30 | PKR 56.88/capsule | 🔒 Pharma Pro |
| Azomont | Azithromycin | 500 mg | Tablet | 6's | 100697 | PKR 507.81 | PKR 84.64/tablet | 🔒 Pharma Pro |
| C-Mox Fort Dry Susp | Amoxicillin + clavulanic acid | 250 mg + 62.5 mg / 5 mL | Dry suspension | 60ml | 024021 | PKR 143.39 | PKR 2.39/mL | 🔒 Pharma Pro |
| Cardil | Enalapril | 5 mg | Tablet | 20's | 016682 | PKR 178.33 | PKR 8.92/tablet | 🔒 Pharma Pro |
| Cardil | Enalapril | 10 mg | Tablet | 20's | 016683 | PKR 366.08 | PKR 18.30/tablet | 🔒 Pharma Pro |
| Cardiosil | Amlodipine | 5 mg | Tablet | 20's | 018058 | PKR 275.49 | PKR 13.77/tablet | 🔒 Pharma Pro |
| Clamont Granules | Clarithromycin | 125 mg | Granules | 60 ml | 129531 | PKR 412.53 | PKR 6.88/mL | No comparator |
| Clamont Tabs | Clarithromycin | 250 mg | Tablet | 10's | 015859 | PKR 756.13 | PKR 75.61/tablet | 🔒 Pharma Pro |
| Clamont Tabs | Clarithromycin | 500 mg | Tablet | 10's | 015860 | PKR 1,182.16 | PKR 118.22/tablet | 🔒 Pharma Pro |
| Clotles SS | Enoxaparin | 20 mg | Injection | 2's | 057407 | PKR 716.54 | PKR 358.27/vial/unit | No comparator |
| Clotles SS | Enoxaparin | 80 mg/mL | Injection | 1's | 068054 | PKR 886.50 | PKR 886.50/vial/unit | No comparator |
| Clotles SS | Enoxaparin | 40 mg | Injection | 1ml x 2's | 074149 | PKR 1,711.69 | PKR 855.85/mL | No comparator |
| Clotles SS | Enoxaparin | 40 mg | Injection | 2's | 074149 | PKR 1,285.70 | PKR 642.85/vial/unit | 🔒 Pharma Pro |
| Clotles SS | Enoxaparin | 60 mg | Injection | 1ml x 2's | 074150 | PKR 2,506.16 | PKR 1,253.08/mL | 🔒 Pharma Pro |
| Clotles SS | Enoxaparin | 60 mg | Injection | 2's | 074150 | PKR 1,650.39 | PKR 825.20/vial/unit | 🔒 Pharma Pro |
| Clotles Tabs | Clopidogrel | 75 mg | Tablet | 10's | 034350 | PKR 293.13 | PKR 29.31/tablet | 🔒 Pharma Pro |
| Diocid | Gliclazide | 80 mg | Tablet | 20's | 015851 | PKR 250.03 | PKR 12.50/tablet | 🔒 Pharma Pro |
| Diocid | Gliclazide | 30 mg | Tablet | 30's | 110867 | PKR 408.92 | PKR 13.63/tablet | 🔒 Pharma Pro |
| Diocid | Gliclazide | 60 mg | Tablet | 30's | 110868 | PKR 678.20 | PKR 22.61/tablet | 🔒 Pharma Pro |
| Eglocard | Simvastatin | 10 mg | Tablet | 10's | 027283 | PKR 361.42 | PKR 36.14/tablet | 🔒 Pharma Pro |
| Eglocard | Simvastatin | 20 mg | Tablet | 20’s | 027284 | PKR 1,131.77 | PKR 56.59/tablet | 🔒 Pharma Pro |
| Eglocard | Simvastatin | 20 mg | Tablet | 10's | 027284 | PKR 565.88 | PKR 56.59/tablet | 🔒 Pharma Pro |
| Hiject | Cefuroxime | 750 mg | Injection | 1's | 036419 | PKR 216.22 | PKR 216.22/vial/unit | 🔒 Pharma Pro |
| Hiject | Cefuroxime | 1.5 g | Injection | 1's | 036420 | PKR 389.20 | PKR 389.20/vial/unit | 🔒 Pharma Pro |
| Hiject | Cefuroxime | 250 mg | Injection | 5 Vial | 037308 | PKR 293.13 | PKR 58.63/vial/unit | 🔒 Pharma Pro |
| Himet | Metformin | 500 mg | Tablet | 50's | 034967 | PKR 132.69 | PKR 2.65/tablet | 🔒 Pharma Pro |
| Himet | Metformin | 1 g | Tablet | 50's | 034968 | PKR 171.63 | PKR 3.43/tablet | 🔒 Pharma Pro |
| Himet | Metformin | 850 mg | Tablet | 50's | 038349 | PKR 122.59 | PKR 2.45/tablet | 🔒 Pharma Pro |
| Himet | Metformin | 850 mg | Tablet | 30's | 038349 | PKR 63.40 | PKR 2.11/tablet | 🔒 Pharma Pro |
| Himet | Metformin | 500 mg | Extended-release tablet | 50's | 102385 | PKR 133.14 | PKR 2.66/tablet | 🔒 Pharma Pro |
| Himovir | Tenofovir disoproxil | 300 mg | Tablet | 30's | 095857 | PKR 5,824.39 | PKR 194.15/tablet | 🔒 Pharma Pro |
| Hipram Tabs | Citalopram | 20 mg | Tablet | 14's | 041752 | PKR 880.32 | PKR 62.88/tablet | 🔒 Pharma Pro |
| Hipres Tabs | Escitalopram | 20 mg | Tablet | 14's | 064503 | PKR 1,109.65 | PKR 79.26/tablet | 🔒 Pharma Pro |
| Hixamic | Tranexamic acid | 500 mg/5 mL | Injection | 10's | 047937 | PKR 1,204.05 | PKR 120.41/vial/unit | 🔒 Pharma Pro |
| Hizolid Tabs | Linezolid | 600 mg | Tablet | 12's | 038030 | PKR 5,351.75 | PKR 445.98/tablet | 🔒 Pharma Pro |
| Imazole | Clotrimazole | 100 mg | Vaginal tablet | 6's | 018056 | PKR 183.82 | PKR 30.64/tablet | 🔒 Pharma Pro |
| Imazole | Clotrimazole | 500 mg | Vaginal tablet | 1's | 018057 | PKR 160.48 | PKR 160.48/tablet | 🔒 Pharma Pro |
| Klofix | Omeprazole | 20 mg | Capsule | 14's | 015865 | PKR 990.99 | PKR 70.79/capsule | 🔒 Pharma Pro |
| Klofix | Omeprazole | 10 mg | Capsule | 1's | 018049 | PKR 49.91 | PKR 49.91/capsule | 🔒 Pharma Pro |
| Locgin Tabs | Moxifloxacin | 400 mg | Tablet | 5's | 052725 | PKR 994.56 | PKR 198.91/tablet | 🔒 Pharma Pro |
| Novosef | Ceftriaxone | 500 mg | Injection | 1 Vial | 019154 | PKR 454.36 | PKR 454.36/vial/unit | 🔒 Pharma Pro |
| Novosef | Ceftriaxone | 500 mg | Injection | 1 Vial | 019155 | PKR 454.26 | PKR 454.26/vial/unit | 🔒 Pharma Pro |
| Novosef | Ceftriaxone | 1 g | Powder for IV injection | 1 Vial | 019156 | PKR 894.22 | PKR 894.22/vial/unit | 🔒 Pharma Pro |
| Novosef | Ceftriaxone | 1 g | IM injection | 1 Vial | 019157 | PKR 894.22 | PKR 894.22/vial/unit | 🔒 Pharma Pro |
All 33 Himont Pharmaceuticals brands in Pakistan
- Akafin Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 400 mg tablet
- Atrocard Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Azomont Azithromycin · 250 mg capsule, 500 mg tablet
- C-Mox Fort Dry Susp Amoxicillin + clavulanic acid · 250 mg + 62.5 mg / 5 mL suspension
- Cardil Enalapril · 10 mg tablet, 5 mg tablet
- Cardiosil Amlodipine · 5 mg tablet
- Clamont Granules Clarithromycin · 125 mg granules
- Clamont Tabs Clarithromycin · 250 mg tablet, 500 mg tablet
- Clotles SS Enoxaparin · 20 mg injection, 40 mg injection, 60 mg injection
- Clotles Tabs Clopidogrel · 75 mg tablet
- Diocid Gliclazide · 30 mg tablet, 60 mg tablet, 80 mg tablet
- Eglocard Simvastatin · 10 mg tablet, 20 mg tablet
- Hiject Cefuroxime · 1.5 g injection, 250 mg injection, 750 mg injection
- Himet Metformin · 1 g tablet, 500 mg tablet, 850 mg tablet
- Himovir Tenofovir disoproxil · 300 mg tablet
- Hipram Tabs Citalopram · 20 mg tablet
- Hipres Tabs Escitalopram · 20 mg tablet
- Hixamic Tranexamic acid · 500 mg/5 mL injection
- Hizolid Tabs Linezolid · 600 mg tablet
- Imazole Clotrimazole · 100 mg pessary, 500 mg pessary
- Klofix Omeprazole · 10 mg capsule, 20 mg capsule
- Locgin Tabs Moxifloxacin · 400 mg tablet
- Novosef Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Orcid Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Sedinor Loratadine · 10 mg tablet
- Sefoban Cefotaxime · 0.25 g injection, 0.5 g injection, 1.0 g injection
- THININ Heparin sodium · 5000 IU/mL injection
- Tysen Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
- Xesafin Dry Susp Cephalexin · 250 mg/5 mL suspension
- Xesafin Susp Cephalexin · 125 mg/5 mL suspension
- Xesfain Cephalexin · 250 mg capsule, 500 mg capsule
- Zeljin Empagliflozin · 10 mg tablet, 25 mg tablet
- Zostat Losartan · 50 mg tablet
Himont Pharmaceuticals: common questions
How many products does Himont Pharmaceuticals have in Pakistan?
Himont Pharmaceuticals (Pvt.) Ltd has 70 registered medicine presentations in Pakistan, sold under 33 brands and covering 30 generic medicines.
What are the main brands of Himont Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Clotles SS (Enoxaparin), Novosef (Ceftriaxone), Himet (Metformin), Akafin (Ibuprofen) and Atrocard (Atorvastatin). This is not a sales ranking.
Which therapy areas does Himont Pharmaceuticals cover?
The most products are in Anti-infectives (32), Cardiovascular (10), Hematology & thrombosis (10), Endocrine & metabolic (10) and Pain & musculoskeletal (3).
Where can I see Himont Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.